OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
The two cardinal symptoms of depression are heightened negative affect (NA) and diminished positive affect (PA). Existing psychosocial treatments for depression focus on reducing NA but arguably neglect increasing PA, which may contribute to sub-optimal treatment outcomes. This talk will present the rationale as to why targeting PA may be helpful, report secondary analyses of RCTs evaluating how well existing treatments repair PA, present findings from basic science work evaluating what mechanisms lead to blunted PA, and describe the development and preliminary evaluation of Augmented Depression Therapy (ADepT) to target PA. In particular clinical and health economic findings from a recent pilot randomized controlled trial (trial registration; ISCRTN85278228) will be presented, where 82 depressed patients were randomized to individual face-to-face ADepT (15 acute and 5 booster sessions) or Cognitive Behavioural Therapy (CBT; 20 acute sessions) and followed up over an 18m period.
